Literature DB >> 26879740

Diagnosis and Treatment of Childhood Meningitis Caused by Streptococcus bovis Group.

Sannya Vidyadhar Hede1.   

Abstract

Streptococcus bovis is a rare, but important cause of bacterial meningitis in children. Since its discovery in the early 1970s, the pathogen has undergone multiple taxonomic changes producing four distinct subspecies today, the most prevalent of which is S. gallolyticus subsp pasteurianus in infants and children. While initially reported as sporadic case reports, there is a growing body of literature documenting invasive disease primarily in neonates and infants clinically indistinguishable from group B streptococcus. In this review, I discuss the taxonomic evolution of S. bovis meningitis and its subsequent clinical diagnosis, manifestations and treatment in children.

Entities:  

Keywords:  Meningitis; S. bovis; S. gallolyticus

Year:  2016        PMID: 26879740     DOI: 10.1007/s11908-016-0519-8

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  30 in total

1.  Late-onset group B streptococcal infection in identical twins: insight to disease pathogenesis.

Authors:  Kelly S Doran; Vivian M Benoit; Robert E Gertz; Bernard Beall; Victor Nizet
Journal:  J Perinatol       Date:  2002-06       Impact factor: 2.521

2.  A longitudinal case series description of meningitis due to Streptococcus gallolyticus subsp. pasteurianus in infants.

Authors:  J Michael Klatte; Jill E Clarridge; Denise Bratcher; Rangaraj Selvarangan
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

3.  Streptococcus bovis meningitis in an otherwise healthy infant.

Authors:  Akihisa Okumura; Hideaki Takahashi; Akimasa Ogawa; Kuniyoshi Kuno; Kazuyoshi Watanabe
Journal:  Clin Pediatr (Phila)       Date:  2002-09       Impact factor: 1.168

4.  Performance of the new VITEK 2 GP card for identification of medically relevant gram-positive cocci in a routine clinical laboratory.

Authors:  Guido Funke; Pascale Funke-Kissling
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

5.  A cluster of bloodstream infections caused by Streptococcus gallolyticus subspecies pasteurianus that involved 5 preterm neonates in a university hospital during a 2-month period.

Authors:  Nathalie Floret; Pascale Bailly; Michelle Thouverez; Catherine Blanchot; Dolores Alez-Martin; Alain Menget; Gérard Thiriez; Bruno Hoen; Daniel Talon; Xavier Bertrand
Journal:  Infect Control Hosp Epidemiol       Date:  2010-02       Impact factor: 3.254

6.  Carriage of group D streptococci in the human bowel.

Authors:  C J Noble
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411

7.  Taxonomic dissection of the Streptococcus bovis group by analysis of manganese-dependent superoxide dismutase gene (sodA) sequences: reclassification of 'Streptococcus infantarius subsp. coli' as Streptococcus lutetiensis sp. nov. and of Streptococcus bovis biotype 11.2 as Streptococcus pasteurianus sp. nov.

Authors:  Claire Poyart; Gilles Quesne; Patrick Trieu-Cuot
Journal:  Int J Syst Evol Microbiol       Date:  2002-07       Impact factor: 2.747

8.  Recognition of group D streptococcal species of human origin by biochemical and physiological tests.

Authors:  R R Facklam
Journal:  Appl Microbiol       Date:  1972-06

9.  Streptococcus gallolyticus subsp. pasteurianus meningitis in an infant.

Authors:  Yoshiko Takahashi; Naruhiko Ishiwada; Junko Tanaka; Kiyofumi Okusu; Sadahiro Ichimura; Haruka Hishiki; Setsuo Ota; Yoichi Kohno
Journal:  Pediatr Int       Date:  2014-04       Impact factor: 1.524

10.  Streptococcus bovis meningitis in a neonate.

Authors:  C R Fikar; J Levy
Journal:  Am J Dis Child       Date:  1979-11
View more
  1 in total

1.  Inducible Expression of both ermB and ermT Conferred High Macrolide Resistance in Streptococcus gallolyticus subsp. pasteurianus Isolates in China.

Authors:  Meixia Li; Chao Cai; Juan Chen; Changwei Cheng; Guofu Cheng; Xueying Hu; Cuiping Liu
Journal:  Int J Mol Sci       Date:  2016-09-22       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.